Emmes appoints Peter Ronco as CEO
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
InvaGen has received 5 inspectional observations in Form 483
The market capitalization of the company stood at Rs. 7,000 crore +
Subscribe To Our Newsletter & Stay Updated